We found that 5SGlcNAc treatment inhibited the formation of a vimentin meshwork around the inclusion, consistent with a requirement for vimentin glycosylation in IF remodeling during Chlamydia infection (Figure 5A). The gene discussed is VIM; the disease is chlamydia infectious disease.